Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
- 31 March 1995
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 16 (3) , 117-121
- https://doi.org/10.1016/0167-5699(95)80125-1
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Signals and signs for lymphocyte responsesCell, 1994
- Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B CellsScience, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993
- Molecular Mechanisms Used by Tumors to Escape Immune RecognitionJournal of Immunotherapy, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cellsCancer Immunology, Immunotherapy, 1992